Lawyer Steve Ruby West Virginia takes a closer look at news of a crucial opioid trial's postponement following continued coronavirus delays.

CHARLESTON, WV, USA, September 4, 2020 /EINPresswire.com/ -- Postponed in response to the ongoing coronavirus pandemic, multiple opioid manufacturers from across the U.S. continue to await trial. A celebrated Charleston-based attorney, Steve Ruby West Virginia takes a more detailed look at the case in hand.

A decision was made earlier this year by the courts to postpone a widely talked about the trial against a number of pharmaceutical companies and their distributors pertaining to the opioid crisis affecting large swathes of the United States, according to Steve Ruby West Virginia. The official line, the lawyer says, concerning the postponement of the trial, cites continuing coronavirus delays.

The trial, however, both Steve Ruby West Virginia and the courts have said, must not be delayed even a single moment longer than is absolutely necessary.

Several famous companies, it's reported, involved not just in the production of opioids, but also the marketing of opioid-based drugs, are currently fielding all manner of lawsuits from various sides. Defendants in the specific case in question, meanwhile, are said to include manufacturers Purdue Pharma, Johnson & Johnson, and Allergan, plus distributors including Cardinal, McKesson, and Rochester.

Widely deemed responsible for a large proportion of America's ongoing opioid crisis, around 50,000 U.S. citizens now die from overdoses every year stemming from prescription and non-prescription opioid drugs combined, according to the latest figures. Facilitated by opioid manufacturers and their distributors, the same figures also suggest that around 1.7 million people in the United States currently struggle with addiction to prescription-only opioid drugs – a number backed up by data from the Center for Behavioral Health Statistics and Quality.

Caroline Hunter
Web Presence, LLC
+17862338220
email us here